Burns Thomas William 4

What Happened
Thomas W. Burns, a director of Pulmonx Corp (LUNG), received an award of 40,000 Restricted Stock Units (RSUs) on June 5, 2026. The grant is reported at $0.00 per share (total reported value $0) because RSUs represent a future right to receive shares rather than an immediate purchase. The RSUs are payable solely in common stock upon vesting.

Key Details

• Transaction date: June 5, 2026; Form 4 filed June 9, 2026.
• Transaction type/code: Award/Grant (A). Price reported: $0.00; total reported consideration: $0.
• Vesting: RSUs vest on the earlier of (i) the one-year anniversary of the grant (June 5, 2027, or next business day if not a business day) or (ii) the date of the Annual Meeting of Stockholders for the year after the grant. RSUs payable solely in common stock (no cash settlement).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Filing timeliness: Form filed on 2026-06-09 (see Form 4 for any tardiness notation).

Context
RSUs are a compensatory grant that convert into actual shares only when they vest; they do not represent immediate sale or purchase activity. Because this is an award (not a purchase or sale), it does not by itself signal buying or selling sentiment — value will depend on Pulmonx’s share price at vesting and any tax withholding rules that may apply at distribution.